These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17669215)

  • 1. Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239.
    Genescà M; Li J; Fritts L; Chohan P; Bost K; Rourke T; Blozis SA; McChesney MB; Miller CJ
    J Med Primatol; 2007 Aug; 36(4-5):266-75. PubMed ID: 17669215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
    Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
    J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus.
    Genescà M; McChesney MB; Miller CJ
    PLoS One; 2010 Mar; 5(3):e9814. PubMed ID: 20352116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge.
    Busch M; Abel K; Li J; Piatak M; Lifson JD; Miller CJ
    Vaccine; 2005 Jul; 23(31):4036-47. PubMed ID: 15963361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
    Abel K; Compton L; Rourke T; Montefiori D; Lu D; Rothaeusler K; Fritts L; Bost K; Miller CJ
    J Virol; 2003 Mar; 77(5):3099-118. PubMed ID: 12584336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus.
    Stone M; Ma ZM; Genescà M; Fritts L; Blozois S; McChesney MB; Miller CJ
    Virology; 2009 Sep; 392(2):260-70. PubMed ID: 19647847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques.
    Trunova N; Tsai L; Tung S; Schneider E; Harouse J; Gettie A; Simon V; Blanchard J; Cheng-Mayer C
    Virology; 2006 Aug; 352(1):169-77. PubMed ID: 16730772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
    Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M
    Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.
    Genescà M; Ma ZM; Wang Y; Assaf B; Qureshi H; Fritts L; Huang Y; McChesney MB; Miller CJ
    J Virol; 2012 Sep; 86(17):9188-200. PubMed ID: 22696662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6.
    Genescà M; McChesney MB; Miller CJ
    J Intern Med; 2009 Jan; 265(1):67-77. PubMed ID: 19093961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.
    Genescà M; Skinner PJ; Hong JJ; Li J; Lu D; McChesney MB; Miller CJ
    J Virol; 2008 Nov; 82(22):11181-96. PubMed ID: 18787003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depo-Provera does not alter disease progression in SIVmac-infected female Chinese rhesus macaques.
    Sanders-Beer B; Babas T; Mansfield K; Golightly D; Kramer J; Bowlsbey A; Sites D; Nieves-Duran L; Lin S; Rippeon S; Donnelly G; Rhodes L; Spano YE
    AIDS Res Hum Retroviruses; 2010 Apr; 26(4):433-43. PubMed ID: 20377424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
    J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum.
    LaFranco-Scheuch L; Abel K; Makori N; Rothaeusler K; Miller CJ
    J Virol; 2004 Jun; 78(12):6399-408. PubMed ID: 15163733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study to assess the safety and efficacy of a live-attenuated SHIV vaccine in long term immunized rhesus macaques.
    Yankee TM; Sheffer D; Liu Z; Dhillon S; Jia F; Chebloune Y; Stephens EB; Narayan O
    Virology; 2009 Jan; 383(1):103-11. PubMed ID: 18986665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques.
    Abel K; La Franco-Scheuch L; Rourke T; Ma ZM; De Silva V; Fallert B; Beckett L; Reinhart TA; Miller CJ
    J Virol; 2004 Jan; 78(2):841-54. PubMed ID: 14694116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
    Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.
    Sutton MS; Burns CM; Weiler AM; Balgeman AJ; Braasch A; Lehrer-Brey G; Friedrich TC; O'Connor SL
    J Virol; 2016 Jun; 90(12):5541-5548. PubMed ID: 26962218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.